Diseases, Conditions, Syndromes

Positive results for Lilly and Regeneron COVID antibodies

US pharmaceutical company Eli Lilly's combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday.

Diseases, Conditions, Syndromes

After year-long sprint, Covid-19 vaccines finally at hand

Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release.

page 24 from 40